Rare Disease MSL Team Excellence: Benchmarking Roles and Staffing Levels

• Rare Disease Staffing Levels: Traditional MSLs vs. Hybrid MSLs
• Drivers of Rare Disease Field Team Evolution
• Medical vs. Commercial Field Resourcing

• How many MSLs and senior MSLs of each type (Traditional MSLs vs. Hybrid MSLs vs. Virtual MSLs) are currently staffed to the rare disease field team?
• Average number of rare disease MSLs; MSL-to-senior MSL ratio at benchmark rare disease organizations
• How effective are each of the listed MSL job roles in rare disease segment?
• How critical have each of the listed factors been in shaping the current size and composition of roles within the rare disease field team?
• Predicted changes in rare disease MSL staffing levels over the next 12-24 months
• How many staff (FTEs) are currently allocated to the listed rare disease field team roles?

• Field-based vs. Hybrid MSLs: Some 72% of organizations make use of traditional “field-based” MSLs, while another 56% use “hybrid” MSLs – but few organizations use both types in a strategically complementary manner. For many companies, the difference between field-based and hybrid MSLs is largely a semantic, as both types tend to operate in a similar manner.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.